Bruce R. Blazar

90.1k citations

843 papers · 58.3k indexed · 18 hit papers · h-index 119

Immunology top 0.01%
Hematology top 0.01%
Oncology top 0.02%
Molecular Biology top 0.5%
Genetics top 0.05%

Co-authors: Angela Panoskaltsis‐Mortari Daniel J. Weisdorf Jeffrey S. Miller John E. Wagner William J. Murphy Todd E. DeFor Patricia A. Taylor Robert Zeiser
Topics: Immune Cell Function and Interaction (361 papers)Hematopoietic Stem Cell Transplantation (359 papers)T-cell and B-cell Immunology (291 papers)
Cited by: Hematology Immunology Transplantation
Journals: Nature Science New England Journal of Medicine
Partner nations: United States United Kingdom Japan

In The Last Decade

Bruce R. Blazar

825 papers receiving 57.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

2006 2.7k citations Bruce R. Blazar et al. profile →
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

2010 1.6k citations Bruce R. Blazar et al. The Journal of Experimental Medicine profile →
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

2005 1.4k citations Jeffrey S. Miller, Angela Panoskaltsis‐Mortari et al. Blood profile →
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

2002 849 citations Bruce R. Blazar et al. Blood profile →
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

2010 805 citations Claudio G. Brunstein, Jeffrey S. Miller et al. Blood profile →
Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

2017 777 citations Bruce R. Blazar et al. profile →
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

2002 743 citations John E. Wagner, Juliet N. Barker et al. Blood profile →
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

2017 724 citations Alice O. Kamphorst, Andreas Wieland et al. Science profile →
IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells

2007 656 citations Bruce R. Blazar et al. profile →
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

2007 652 citations Phillip Chandler, Miyuki Azuma et al. profile →
Advances in graft-versus-host disease biology and therapy

2012 626 citations Bruce R. Blazar, William J. Murphy et al. profile →
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

2004 606 citations Daniel J. Weisdorf, Bruce R. Blazar et al. profile →
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

2004 597 citations Juliet N. Barker, Daniel J. Weisdorf et al. Blood profile →
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

2011 532 citations Qing Zhou, Meghan E. Munger et al. Blood profile →
Human Plasmacytoid Dendritic Cells Activated by CpG Oligodeoxynucleotides Induce the Generation of CD4+CD25+ Regulatory T Cells

2004 509 citations Xueqing Liang, Angela Panoskaltsis‐Mortari et al. profile →
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

2017 445 citations Bruce R. Blazar et al. profile →
Mitochondrial Integrity Regulated by Lipid Metabolism Is a Cell-Intrinsic Checkpoint for Treg Suppressive Function

2019 301 citations Keli L. Hippen, Bruce R. Blazar et al. profile →
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

2016 283 citations Steven Z. Pavletic, Jerome Ritz et al. profile →

Peers

Countries citing papers authored by Bruce R. Blazar

Since Specialization

Citations

This map shows the geographic impact of Bruce R. Blazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce R. Blazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce R. Blazar more than expected).

Fields of papers citing papers by Bruce R. Blazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce R. Blazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce R. Blazar. The network helps show where Bruce R. Blazar may publish in the future.

Co-authorship network of co-authors of Bruce R. Blazar

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce R. Blazar. A scholar is included among the top collaborators of Bruce R. Blazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce R. Blazar. Bruce R. Blazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Belumosudil for Chronic Graft-Versus-Host Disease after 2 or More Prior Lines of Systemic Therapy: 3-Year Follow-up of the Rockstar Study 2024 ·Transplantation and Cellular Therapy ·Stephanie J. Lee,Corey Cutler,Steven Z. Pavletic,Bruce R. Blazar	2
2	Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results 2021 ·Clinical Cancer Research ·Joseph Pidala,Kelly Walton,Hany Elmariah,Jongphil Kim,Asmita Mishra,Nelli Bejanyan,Taiga Nishihori,Farhad Khimani,Lia Perez,Rawan Faramand,Marco L. Davila,Michael L. Nieder,Elizabeth M. Sagatys,Shernan G. Holtan,Nicholas J. Lawrence,Harshani R. Lawrence,Bruce R. Blazar,Claudio Anasetti,Saı̈d M. Sebti,Brian C. Betts	15
3	IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer 2020 ·Blood Advances ·Scott N. Furlan,Karnail Singh,Christina Lopez,Victor Tkachev,Daniel J. Hunt,(unknown),Kayla Betz,Bruce R. Blazar,Cole Trapnell,Leslie S. Kean	30
4	Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37 2018 ·Cancer Immunology Research ·Dhifaf Sarhan,Keli L. Hippen,(unknown),(unknown),Xianghua Luo,Todd Lenvik,Julie Curtsinger,Zachary Davis,Bin Zhang,Sarah Cooley,Frank Cichocki,Bruce R. Blazar,Jeffrey S. Miller	93
5	Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependentbreakdown → 2017 ·Science ·Alice O. Kamphorst,Andreas Wieland,Tahseen H. Nasti,Shu Yang,Ruan Zhang,Daniel L. Barber,Bogumila T. Konieczny,(unknown),Lydia Koenig,Yu Ke,Gabriel Sica,Arlene H. Sharpe,Gordon J. Freeman,Bruce R. Blazar,Laurence A. Turka,Taofeek K. Owonikoko,Rathi N. Pillai,Suresh S. Ramalingam,Koichi Araki,Rafi Ahmed	724
6	Acute graft-versus-host disease is regulated by an IL-17–sensitive microbiome 2017 ·Blood ·Antiopi Varelias,Kate L. Ormerod,Mark D. Bunting,Motoko Koyama,Kate H. Gartlan,Rachel D. Kuns,Nancy Lachner,Kelly R. Locke,(unknown),Andrea Henden,Ping Zhang,Andrew D. Clouston,Sumaira Z. Hasnain,Michael A. McGuckin,Bruce R. Blazar,Kelli P. A. MacDonald,Philip Hugenholtz,Geoffrey R. Hill	52
7	Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling 2016 ·Cancer Research ·Jianming Li,Christopher T. Petersen,(unknown),(unknown),(unknown),Cynthia R. Giver,Bruce R. Blazar,Edmund K. Waller	17
8	IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function 2016 ·Clinical Cancer Research ·Daniel A. Vallera,Martin Felices,Ron McElmurry,Valarie McCullar,Xianzheng Zhou,Joerg Uwe Schmohl,Bin Zhang,Alexander J. Lenvik,Angela Panoskaltsis‐Mortari,Michael R. Verneris,Jakub Tolar,Sarah Cooley,Daniel J. Weisdorf,Bruce R. Blazar,Jeffrey S. Miller	295
9	Alternative donor hematopoietic cell transplantation for Fanconi anemia 2015 ·Blood ·Margaret L. MacMillan,Todd E. DeFor,Jo‐Anne H. Young,Kathryn E. Dusenbery,Bruce R. Blazar,Arne Slungaard,Heather Zierhut,Daniel J. Weisdorf,John E. Wagner	66
10	Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect 2015 ·Blood ·Claudio G. Brunstein,Jeffrey S. Miller,David H. McKenna,Keli L. Hippen,Todd E. DeFor,Darin Sumstad,Julie Curtsinger,Michael R. Verneris,Margaret L. MacMillan,Bruce L. Levine,James L. Riley,Carl H. June,Chap T. Le,Daniel J. Weisdorf,Philip B. McGlave,Bruce R. Blazar,John E. Wagner	303
11	Immunosuppressive Myeloid Cells Induced by Chemotherapy Attenuate Antitumor CD4+ T-Cell Responses through the PD-1–PD-L1 Axis 2014 ·Cancer Research ·Zhi-Chun Ding,Xiaoyun Lu,Miao Yu,Henrique Lemos,Lei Huang,Phillip Chandler,Kebin Liu,Matthew J. Walters,(unknown),Matthias Mack,Bruce R. Blazar,Andrew L. Mellor,David H. Munn,Gang Zhou	109
12	DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo 2013 ·Blood ·Beau R. Webber,Michelina Iacovino,Si Ho Choi,Jakub Tolar,Michael Kyba,Bruce R. Blazar	16
13	Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function 2012 ·Proceedings of the National Academy of Sciences ·Alexandra Zanin‐Zhorov,(unknown),José U. Scher,Sudha Kumari,David A. Blair,Keli L. Hippen,Bruce R. Blazar,Steven B. Abramson,Juan J. Lafaille,Michael L. Dustin	45
14	Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth 2012 ·Cancer Research ·(unknown),Edwin R. Manuel,Teodora Kaltcheva,(unknown),Joshua D.I. Ellenhorn,Bruce R. Blazar,Don J. Diamond	78
15	Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation 2012 ·Journal of Clinical Oncology ·John Koreth,Kristen E. Stevenson,Haesook T. Kim,Sean M. McDonough,Bhavjot Bindra,Philippe Armand,Vincent T. Ho,Corey Cutler,Bruce R. Blazar,Joseph H. Antin,Robert J. Soiffer,Jerome Ritz,Edwin P. Alyea	104
16	Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells 2011 ·Cancer Research ·Michael R. Olin,Brian M. Andersen,Adam J. Litterman,Patrick T. Grogan,Aaron L. Sarver,(unknown),Xueqing Liang,Wei Chen,Ian F. Parney,Matthew A. Hunt,Bruce R. Blazar,John R. Ohlfest	17
17	Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia 2010 ·Blood ·Qing Zhou,Meghan E. Munger,Steven L. Highfill,Jakub Tolar,Brenda J. Weigel,Megan Riddle,Arlene H. Sharpe,Daniel A. Vallera,Miyuki Azuma,Bruce L. Levine,Carl H. June,William J. Murphy,David H. Munn,Bruce R. Blazar	230
18	Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kineticsbreakdown → 2010 ·Blood ·Claudio G. Brunstein,Jeffrey S. Miller,Qing Cao,David H. McKenna,Keli L. Hippen,Julie Curtsinger,Todd E. DeFor,Bruce L. Levine,Carl H. June,Pablo Rubinstein,Philip B. McGlave,Bruce R. Blazar,John E. Wagner	805
19	Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells 2007 ·The Journal of Experimental Medicine ·Marta Serafini,Scott J. Dylla,Masayuki Oki,Yves Heremans,Jakub Tolar,Yuehua Jiang,Suzanne M. K. Buckley,Beatriz Pelacho,Terry C. Burns,(unknown),Derrick J. Rossi,David Bryder,Angela Panoskaltsis‐Mortari,Matthew J. O’Shaughnessy,Molly Nelson-Holte,G Fine,Irving L. Weissman,Bruce R. Blazar,Catherine M. Verfaillie	75
20	Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease 2007 ·Blood ·Claudio G. Brunstein,Juliet N. Barker,Daniel J. Weisdorf,Todd E. DeFor,Jeffrey S. Miller,Bruce R. Blazar,Philip B. McGlave,John E. Wagner	376

About Bruce R. Blazar

Bruce R. Blazar is a scholar working on Hematology, Immunology and Transplantation, having authored 843 papers that have together received 58.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (361 papers), Hematopoietic Stem Cell Transplantation (359 papers) and T-cell and B-cell Immunology (291 papers). The work is most often cited by research in Hematology (20.2k citations), Immunology (36.0k citations) and Transplantation (1.9k citations). Bruce R. Blazar has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Angela Panoskaltsis‐Mortari, Daniel J. Weisdorf, Jeffrey S. Miller, John E. Wagner, William J. Murphy, Todd E. DeFor, Patricia A. Taylor, Robert Zeiser, Carl H. June and Jakub Tolar. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact